A new U of A clinical trial is testing ultra-early Gamma Knife surgery to stop trigeminal neuralgia before permanent brain ...
As innovation accelerates, outcomes still lag. Veteran care highlights how coordinated systems may be key to advancing mental ...
MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...
A new thermostable vaccine that does not require refrigeration has shown promising early results in a human trial. If ...
Erda-iDRS delivers erdafitinib into the bladder over three months, enabling localised therapy and reducing systemic exposure.
Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...
Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...